Thursday, June 4th | 12:00 PM ET, 6:00 PM CET

Parkinson’s disease symptoms and motor fluctuations often occur outside the clinic, making it difficult to capture the full patient experience through intermittent visits and self-reported diaries alone.

In this webinar, Prof. Francesca Morgante, MD, PhD joins Empatica to explore how continuous monitoring technologies can provide objective insights into patients’ daily experiences with ‘OFF’ periods, helping clinicians better understand symptom variability and treatment response in real-world settings.

The discussion covers the growing role of wearable technology and digital biomarkers in Parkinson’s disease management, and how continuous data collection may support more personalized and proactive care.

 

What we’ll cover:

  • Why ‘OFF’ periods remain challenging to assess in routine clinical practice
  • The limitations of episodic assessments and patient-reported symptom tracking
  • How continuous monitoring can capture real-world motor fluctuations
  • The potential role of wearable technologies in improving treatment insights
  • Emerging opportunities for digital biomarkers in Parkinson’s disease care and research
  • Q&A session on Parkinson’s management, wearable technology, and digital health applications


Secure your spot
Join us to learn how continuous monitoring is reshaping Parkinson’s disease management beyond the clinic.

Register to attend

By clicking Register you consent to being contacted by Empatica Inc. about its products and services and you agree to the terms and conditions stated in the privacy policy.

Our special guests

Francesca Morgante is Professor of Neurology and Eleonor Peel Chair for the study of Ageing and Head of Neuromodulation and Motor Control Section at City, St. George’s University of London. She is an honorary consultant neurologist at St George’s University Hospital, London.
She is specialized in the diagnosis and treatment of Parkinson’s disease, Dystonias, Tremor Syndromes, Rare and complex movement disorders.
Her research interests span from studying the kinematic features and neural mechanisms of movement disorders to developing novel neuromodulation paradigms to treat these neurological conditions. She has published more than 200 papers in peer-reviewed journals and many chapters in books focusing on Movement Disorders.
She is one of the Associate Editors of Movement Disorders Journal and she is on the editorial board of Movement Disorders, Movement Disorders Clinical Practice, and Journal of Neurology. She is the Chair of the Education Committee of the International Parkinson’s Disease and Movement Disorders Society. She is a medical advisor for Parkinson’s Europe and Dystonia Europe

 

Our host

 

About Empatica

Empatica Inc. is a pioneer in continuous, unobtrusive remote health monitoring driven by AI. 
Empatica's FDA-cleared platform and technology are used by thousands of institutional partners for research purposes, in studies examining stress, sleep, epilepsy, migraine, depression, addiction, and other conditions. Its flagship medical wearable, EmbracePlus, has been developed with key partners including HHS, USAMRDC, and the NASA-funded TRISH. Its latest device, EmbraceMini, is the world’s smallest actigraphy device for use in clinical care and research. Empatica is also a global leader in patient-centric wearable epilepsy monitoring. In 2025, Empatica acquired PKG Health, expanding its offering into Parkinson’s Disease.